Impact of Acid-Reducing Agents on the Pharmacokinetics of Pritelivir, a Novel Oral Herpes Simplex Virus (HSV) Helicase-Primase Inhibitor (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 2089; Pres time: Oct 24, 2026; 12:15 PM - 01:30 PM; Location: Poster Hall B-C; No abstract available
PK/PD data • Herpes Simplex • Infectious Disease
|
|
Susanne Bonsmann, Diploma in Chemistry Engineering (she/her/hers); Alexander Birkmann, PhD (he/him/his); Dirk Kropeit, n/a; Cynthia Wat, MBBS MRCP MFPM; Bernadette Surujbally, MSc; Grace Fraczkiewicz, MSc; Marian Geldof, MSc; Ivain Duhil, PharmD; Michiel deVries, PharmD, PhD
|